tirzepatide surpass is the same as metformin better than SURPASS-2: A Study of Tirzepatide Versus Semaglutide Once Weekly SURPASS‑EARLY evaluated starting tirzepatide early – Tirzepatide Matches Dulaglutide in Large

Common Complaints First-month promotional pricing creates sticker shock at renewal No self-service cancellation: you must call or message support to cancel Guarantee conditions changed from 3 months to 5 months, with strict weight-loss thresholds Some reports of medication shipments delayed or never arriving after payment Billing every 28 days continues regardless of shipment timing Packaging quality concerns: vials reported loose or improperly packed in some shipments The complaints cluster around billing practices and expectations management, not around the medication or medical care itself

"The reiterated 2026 guidance was expected by investors, but there is still a high degree of skepticism despite easy comparisons (still a "show me the money" story)," said JPMorgan analyst Andrea Teixeira in a note to clients.

Reconstitution Tip: Cold BAC water works

Over time, studies have shown that patients using semaglutide can lose an average of 15% or more of their body weight